SCHEMBL3222373

SCHEMBL3222373

O=C(C=Cc1ccc(O)cc1)CC(=O)C=Cc1cccc(C(=O)O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 3/20 0.77
BACE1 P56817 13/20 0.68
AKR1B1 P15121 2/20 0.65
MAOB P27338 2/20 0.65
AKR1B10 O60218 1/20 0.65
PTGS2 P35354 1/20 0.65
GLO1 Q04760 1/20 0.65
CAMK2A Q9UQM7 1/20 0.65
P4HB P07237 1/20 0.61
CYP3A4 P08684 1/20 0.54
HSPD1 P10809 1/20 0.54
PKM P14618 1/20 0.54
NFKB1 P19838 1/20 0.54
RAB9A P51151 1/20 0.54
HSPE1 P61604 1/20 0.54
NFKB2 Q00653 1/20 0.54
KMT2A Q03164 1/20 0.54
RELA Q04206 1/20 0.54
ABCB1 P08183 1/20 0.53
MAOA P21397 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222361 1.00 TTR (0.77) TTRBACE1AKR1B1MAOBAKR1B10
SCHEMBL22887493 0.88 TTR (1.00) TTRMAOBP4HBCYP3A4HSPD1
SCHEMBL22887517 0.88 TTR (1.00) TTRMAOBP4HBCYP3A4HSPD1
SCHEMBL3211591 0.84 BACE1 (0.75) BACE1AKR1B1MAOBAKR1B10PTGS2
SCHEMBL3211603 0.84 BACE1 (0.75) BACE1AKR1B1MAOBAKR1B10PTGS2
SCHEMBL3214161 0.82 BACE1 (0.68) BACE1AKR1B1MAOBAKR1B10PTGS2
SCHEMBL3214146 0.82 BACE1 (0.68) BACE1AKR1B1MAOBAKR1B10PTGS2
SCHEMBL30383950 0.82 P4HB (0.78) TTRMAOBP4HBCYP3A4HSPD1
SCHEMBL11452322 0.82 P4HB (0.78) TTRMAOBP4HBCYP3A4HSPD1
SCHEMBL11452324 0.82 P4HB (0.78) TTRMAOBP4HBCYP3A4HSPD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8962674-B2 Curcumin derivative TOKYO INSTITUTE OF TECHNOLOGY (JP) 2015-02-24 US disclosed
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE TOKYO INSTITUTE OF TECHNOLOGY (JP) 2010-02-25 US disclosed
EP-2123637-A1 NOVEL CURCUMIN DERIVATIVE Tokyo Institute of Technology (JP) 2009-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048901-A1 NOVEL CURCUMIN DERIVATIVE BACE1, APP, BACE2 TTR 1425/4885BACE1 1/4885AKR1B1 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.